Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Momenta Pharmaceuticals, Inc. (MNTA)

MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
floblu14 Member Profile
Member Level 
Followed By 16
Posts 2,225
Boards Moderated 0
Alias Born 07/20/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2015 1:56:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2015 10:26:36 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/9/2015 10:31:11 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 3/6/2015 5:19:39 PM
Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialyla... "GlobeNewswire Inc." - 3/2/2015 3:34:45 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/27/2015 3:17:50 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 2/27/2015 3:04:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/26/2015 1:44:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 3:00:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 2:57:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 2:55:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 2:48:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 2:42:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/25/2015 2:35:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 4:31:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 4:29:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 4:16:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 4:13:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 4:05:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2015 2:32:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/23/2015 6:07:05 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/20/2015 3:04:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/20/2015 3:03:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/20/2015 3:03:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/20/2015 3:03:01 PM
floblu14 Member Level  Wednesday, 12/07/11 09:36:20 AM
Re: None
Post # of 13227 
MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

MOMENTA PHARMACEUTICALS, INC., Plaintiff-Appellee, and
SANDOZ, INC., Plaintiff-Appellee,
v.
AMPHASTAR PHARMACEUTICALS, INC., INTERNATIONAL MEDICATION SYSTEMS, LTD., WATSON PHARMACEUTICALS, INC. and WATSON PHARMA, INC., Defendants-Appellants.

Nos. 2012-1062, 2012-xxxx, 2012-xxxx

United States Court of Appeals, Federal Circuit.


December 6, 2011.


This order is nonprecedential

ORDER

Upon consideration of the November 17, 2011 order expediting briefing on the merits of this appeal, the motions to consolidate this appeal with forthcoming appeals, the motion for leave to file a corrected opening brief, the motion for leave to file public and confidential versions of its reply in support of its motion to stay the injunction, and the motions to amend the official caption to add Watson Pharma, Inc.,

IT IS ORDERED THAT:
(1) Oral argument for the merits of the appeal is scheduled to be held at 10 a.m., January 24, 2012, in Courtroom 201. The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than January 9, 2012.
(2) The motions to consolidate will be granted and the official caption will be amended to add the appeal numbers from the district court's November 23, 2011 order denying their motion to dissolve the injunction and the district court's December 2, 2011 order denying their emergency motion for relief from the injunction, when those new appeals are docketed by this court.
(3) The motions to reform the caption are granted. Watson Pharma, Inc. is added to the caption. The revised official caption is reflected above.

http://www.leagle.com/xmlResult.aspx?xmldoc=In%20FCO%2020111206163.xml&docbase=CSLWAR3-2007-CURR


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist